ARMATA PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$81.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-21.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2025-03-21
- ARMATA PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$81.00K.
- ARMATA PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2019 was -$663.00K.
- ARMATA PHARMACEUTICALS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2018 was -$145.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|
| 2023-12-31 | -$81.00K 10-K · filed 2025-03-21 |
| 2019-12-31 | -$663.00K 10-K · filed 2021-03-18 |
| 2018-12-31 | -$145.00K 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |